SCHEMBL6986620

SCHEMBL6986620

Cc1nc(N2CCCCC2)c[nH]1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CRHBP P24387 1/20 0.46
CRHR2 Q13324 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
KDM4E B2RXH2 6/20 0.41
L3MBTL1 Q9Y468 4/20 0.41
GAA P10253 4/20 0.41
ACHE P22303 1/20 0.41
TDP1 Q9NUW8 3/20 0.40
CASP1 P29466 1/20 0.40
CASP4 P49662 1/20 0.40
CASP5 P51878 1/20 0.40
HRH4 Q9H3N8 2/20 0.39
CHRM3 P20309 1/20 0.39
PDE4A P27815 1/20 0.39
PDE4B Q07343 1/20 0.39
PDE4C Q08493 1/20 0.39
PDE4D Q08499 1/20 0.39
ALDH1A1 P00352 5/20 0.39
MAPK1 P28482 3/20 0.39
MAPT P10636 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24681505 0.74 PARP1 (0.39) KDM4EGAACASP1HRH4ALDH1A1
SCHEMBL17827822 0.72 SMN1; SMN2 (0.47) CRHBPCRHR2SMN1; SMN2KDM4EL3MBTL1
SCHEMBL15264504 0.71 CASP1 (0.37) CRHBPCRHR2SMN1; SMN2TDP1CASP1
SCHEMBL20089107 0.66 DGAT2 (0.43) TDP1ALDH1A1MAPK1MAPTPOLB
SCHEMBL5791348 0.65 SMN1; SMN2 (0.68) CRHBPCRHR2SMN1; SMN2KDM4EL3MBTL1
SCHEMBL19758232 0.65 CRHBP (0.44) CRHBPCRHR2SMN1; SMN2KDM4EL3MBTL1
SCHEMBL6467644 0.65 HTR3E (0.70) CRHBPCRHR2SMN1; SMN2KDM4EL3MBTL1
SCHEMBL12677961 0.65 CRHBP (0.49) CRHBPCRHR2SMN1; SMN2KDM4EL3MBTL1
SCHEMBL5387398 0.65 SMN1; SMN2 (0.44) CRHBPCRHR2SMN1; SMN2KDM4EL3MBTL1
SCHEMBL23258651 0.64 MAPT (0.41) CRHBPCRHR2SMN1; SMN2KDM4EL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1337251-A1 MONOCYCLIC OR BICYCLIC CARBOCYCLES AND HETEROCYCLES AS FACTOR XA INHIBITORS Bristol-Myers Squibb Pharma Company (US) 2003-08-27 EP disclosed
WO-2002102380-A1 MONOCYCLIC OR BICYCLIC CARBOCYCLES AND HETEROCYCLES AS FACTOR XA INHIBITORS BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2002-12-27 WO disclosed